ArticleAnnals of translational medicine2021

Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients.

Zheng Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.